OSCR

Oscar Health Inc

OSCR, USA

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

https://www.hioscar.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OSCR
stock
OSCR

Oscar Health (OSCR): Reassessing Valuation After New Analyst Coverage and Broward Health Network Expansion simplywall.st

Read more →
OSCR
stock
OSCR

State of Wyoming Raises Stock Position in Oscar Health, Inc. $OSCR MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$14.375

Analyst Picks

Strong Buy

2

Buy

1

Hold

2

Sell

1

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

4.21

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-13.42 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-2.39 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-32.61 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

4.61

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 67.73% of the total shares of Oscar Health Inc

1.

Vanguard Group Inc

(7.6336%)

since

2025/06/30

2.

BlackRock Inc

(6.0951%)

since

2025/06/30

4.

Deerfield Management Co

(4.5056%)

since

2025/06/30

5.

JPMorgan Chase & Co

(3.838%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(2.4984%)

since

2025/07/31

7.

Thrive Capital Management, LLC(NY)

(2.4535%)

since

2025/06/30

8.

State Street Corp

(2.0887%)

since

2025/06/30

9.

Vanguard Small Cap Index

(1.9534%)

since

2025/07/31

10.

Gilder Gagnon Howe & CO LLC

(1.8989%)

since

2025/06/30

11.

Geode Capital Management, LLC

(1.7428%)

since

2025/06/30

12.

iShares Russell 2000 ETF

(1.7135%)

since

2025/08/31

13.

Avantis US Small Cap Value ETF

(1.6726%)

since

2025/08/30

14.

Dimensional Fund Advisors, Inc.

(1.426%)

since

2025/06/30

15.

Capital World Investors

(1.4011%)

since

2025/06/30

16.

American Funds SMALLCAP World A

(1.4011%)

since

2025/06/30

17.

T. Rowe Price US Small-Cap Core Equity

(1.3763%)

since

2025/06/30

18.

Glynn Capital Management, LLC

(1.1641%)

since

2025/06/30

19.

Hennessy Advisors, Inc.

(1.1107%)

since

2025/06/30

20.

Hennessy Cornerstone Mid Cap 30 Inv

(1.1107%)

since

2025/06/30

21.

Vanguard Small Cap Growth Index Inv

(1.1028%)

since

2025/07/31

22.

American Century Companies Inc

(1.084%)

since

2025/06/30

23.

Morgan Stanley - Brokerage Accounts

(1.0576%)

since

2025/06/30

24.

T. Rowe Price Small-Cap Value

(0.9019%)

since

2025/07/31

25.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8568%)

since

2025/07/31

26.

Susquehanna International Group, LLP

(0.8485%)

since

2025/06/30

27.

BIT Global Technology Leaders R-I

(0.834%)

since

2025/05/31

28.

Goldman Sachs Group Inc

(0.8191%)

since

2025/06/30

29.

General Catalyst Group Management, LLC

(0.8152%)

since

2025/06/30

30.

Citadel Advisors Llc

(0.7765%)

since

2025/06/30

31.

JPMorgan Value Advantage L

(0.7239%)

since

2025/07/31

32.

Fidelity Small Cap Index

(0.7111%)

since

2025/06/30

33.

Nuveen, LLC

(0.702%)

since

2025/06/30

34.

T. Rowe Price New Horizons

(0.6964%)

since

2025/07/31

35.

T. Rowe Price Small-Cap Stock

(0.6684%)

since

2025/07/31

36.

T. Rowe Price U.S. SC Core Eq Tr-D

(0.667%)

since

2025/06/30

37.

iShares Russell 2000 Growth ETF

(0.6244%)

since

2025/08/31

38.

T. Rowe Price U.S. SC Value Eq Tr-D

(0.6224%)

since

2025/06/30

39.

JPM Large Cap Value - MA

(0.6217%)

since

2025/06/30

40.

JPM US Large Cap Value-Composite

(0.6217%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.92

Latest Release

Date

2025-09-30

EPS Actual

-0.53

EPS Estimate

-0.58

EPS Difference

0.05

Surprise Percent

8.6207%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Not Attractive for GARP(1)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(1.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.